This is in contrast to other tumor types either where FURIN expression predicts a better postoperative disease-free survival such as in hepatocellular carcinoma or where FURIN inhibition can delay the tumorigenic process (salivary gland tumors, skin cancer). This evidence concerns the gene FURIN and neoplasm.